Severe fever with thrombocytopenia syndrome virus
AssigneeI.D.Bio.
InventorsYeo-Jeong Choi, Su-Jin Park, Young-Il Kim, Min-Ah Yu
Life of this patent
Estimating the term…
Loading patent…
AssigneeI.D.Bio.
InventorsYeo-Jeong Choi, Su-Jin Park, Young-Il Kim, Min-Ah Yu
Estimating the term…
The present invention relates to a novel genotype of severe fever with thrombocytopenia syndrome viruses and use thereof as an immunogenic composition. The severe fever with thrombocytopenia syndrome viruses of the present invention are genetically different from conventional severe fever with thrombocytopenia syndrome viruses and are novel viruses taxonomically belonging to three sub-groups of genotype B. In view of the vaccine property that specific genotype viruses alone show only limited protective potential, the novel viruses of the present invention may be advantageously used as a vaccine having excellent cross-immunogenicity for SFTSV.
An immunogenic composition for prevention or treatment of a severe fever with thrombocytopenia syndrome, comprising inactivated severe fever with thrombocytopenia syndrome virus or a gene thereof as an active ingredient, and an adjuvant,
A method for detecting a severe fever with thrombocytopenia syndrome virus antibody, the method comprising:
A method for producing antiserum against a severe fever with thrombocytopenia syndrome virus in a non-human animal, the method comprising:
Dependencies are inferred from the claim text.